Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 6—June 2006
Research

Haemophilus influenzae Type b Reemergence after Combination Immunization

Nik G. Johnson*, Jens U. Ruggeberg*, Gail F. Balfour*, Y. Chen Lee†, Helen Liddy‡, Diane Irving‡, Joanna Sheldon‡, Mary P.E. Slack§, Andrew J. Pollard†, and Paul T. Heath*Comments to Author 
Author affiliations: *St George's University of London, London, United Kingdom; †University of Oxford, Oxford, United Kingdom; ‡St. George's Hospital, London, United Kingdom; §Health Protection Agency Centre for Infections, London, United Kingdom

Main Article

Figure 1

Geometric mean anti-polyribosyl-ribitol phosphate antibody concentration before booster (95% confidence intervals) in 2- to 4-year-old children, according to number of doses of acellular pertussis (aP) containing Haemophilus influenzae type b combination vaccines received in infancy. Number of participants is shown in parentheses. GMC, geometric mean concentration.

Figure 1. Geometric mean anti-polyribosyl-ribitol phosphate antibody concentration before booster (95% confidence intervals) in 2- to 4-year-old children, according to number of doses of acellular pertussis (aP) containing Haemophilus influenzae type b combination vaccines received in infancy. Number of participants is shown in parentheses. GMC, geometric mean concentration.

Main Article

Page created: January 04, 2012
Page updated: January 04, 2012
Page reviewed: January 04, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external